Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

BUY
$1.3 - $3.58 $56,668 - $156,055
43,591 New
43,591 $105,000
Q2 2023

Jul 27, 2023

SELL
$2.15 - $3.49 $3,829 - $6,215
-1,781 Reduced 8.2%
19,948 $46,000
Q1 2023

May 01, 2023

BUY
$1.99 - $2.68 $43,240 - $58,233
21,729 New
21,729 $53,000
Q3 2022

Nov 07, 2022

BUY
$1.94 - $3.43 $26,108 - $46,160
13,458 New
13,458 $32,000
Q3 2020

Dec 11, 2020

SELL
$1.44 - $2.1 $99,766 - $145,492
-69,282 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$1.75 - $2.3 $121,243 - $159,348
69,282 New
69,282 $138,000
Q2 2019

Aug 13, 2019

SELL
$5.35 - $7.11 $188,127 - $250,016
-35,164 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$4.36 - $7.94 $153,315 - $279,202
35,164 New
35,164 $196,000
Q4 2017

Feb 09, 2018

SELL
$8.77 - $12.28 $105,178 - $147,274
-11,993 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$12.17 - $16.3 $145,954 - $195,485
11,993
11,993 $0

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.